Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Genitourinary 2Gastrointestinal 2CNS 2Other solid neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Wilms Tumor 3Sarcoma 3Rhabdomyosarcoma 3Rhabdoid Tumor 3Retinoblastoma 3Medulloblastoma 3Hepatoblastoma 3Central Nervous System Neoplasms 3Carcinoma, Renal Cell 3Sarcoma, Ewing 2Neuroblastoma 2Neoplasms, Germ Cell and Embryonal 2Liver Neoplasms 2Kidney Neoplasms 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Astrocytoma 2Testicular Neoplasms 1Teratoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors 1Melanoma 1Lymphoma 1Glioma 1Familial ependymoma 1Ependymoma 1Digestive System Neoplasms 1

Interventions

Cyclophosphamide 3fludarabine 2Vorinostat 2Sirolimus 2Mesna 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Busulfan 2sodium thiosulfate 1ripretinib 1repotrectinib 1pralsetinib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1lutetium Lu 177 dotatate 1fludarabine phosphate 1etoposide phosphate 1copper dotatate CU-64 1Ursodeoxycholic Acid 1Topotecan 1Thrombopoietin 1Thiotepa 1Therapeutics 1Sunitinib 1Stem Cell Transplantation 1Simvastatin 1Radiotherapy, Image-Guided 1Radiation 1Psychiatric Rehabilitation 1Plicamycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms, Germ Cell and Embryonal × Busulfan × Gastrointestinal × Clear all
NCT01625351 2026-02-06

A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

St. Jude Children's Research Hospital

Phase 1 Completed
23 enrolled
CNSDermatologicGastrointestinalGenitourinaryLymphoidSarcoma

Carcinoma, Renal Cell, Digestive System Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Melanoma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Adenocarcinoma, Clear Cell, Rhabdoid Tumor

NCT01505569 2024-02-26

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Masonic Cancer Center, University of Minnesota

Phase NA Completed
44 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡